RxDoctor Payments Data

Christina Weiland, PA

Physician Assistant · Florence, KYNPI 1912309766

Payments from drug & device makers

$4,793in general payments, 2019–2025

Across 283 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$346
  • Pfizer$311
  • Astellas Pharma US Inc$298
  • Gilead$296
  • GSK$249
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$4,793100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,793 in reported general payments places this provider in the 90th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$20,523
Medicare patients
121
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$27,278
LinzessLinaclotide16$13,909
Celecoxib18$2,116
Duloxetine Hcl46$1,062
Albuterol Sulfate HfaAlbuterol Sulfate43$903
Levothyroxine Sodium67$817
Metronidazole11$816
Atorvastatin Calcium85$730
Metoprolol Succinate42$614
ValacyclovirValacyclovir Hcl11$547
Dicyclomine Hcl26$492
Omeprazole69$468
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav72$467
CefuroximeCefuroxime Axetil19$464
Rosuvastatin Calcium39$462

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$234$27,27821 claims
AbbVieLinzess$1,538$13,90916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Florence

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →